I notice one major difference between RAC and IMU management. The RAC management does not hesitate to use very bullish statements whereas IMU tends to be very down to earth conservative. Compare the two headlines,
IMU: Imugene HER Vaxx shows positive Overall Survival in trial
RAC: Impressive Preclinical Bisantrene Breast Cancer Results
Believe me, if this Her-Vaxx achievement headline is released by RAC's management, it might go something like this:
"Impressive Her-Vaxx blows $48bn Herceptin out of the park in both safety and efficacy results.
IMU Price at posting:
12.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)